Product Description
GS-441524 is a nucleoside analog antiviral drug that has gained attention for its potential use in treating feline infectious peritonitis (FIP). FIP is a serious and often fatal disease in cats caused by a coronavirus, and it can be challenging to treat effectively.
GS-441524 is related to another antiviral drug called Remdesivir, which has been studied for its efficacy against various viruses including coronaviruses like SARS-CoV-2. GS-441524 has shown promise in treating FIP because it can inhibit the replication of the coronavirus responsible for FIP.
|
Appearance |
Transparent liquid, powder or tablets |
|
GS Standard |
99.5%min |
|
Size |
20mg, 7ml/ Vial |
|
Content |
15mg/ml or 20mg/ml |
|
Application |
For CAT FIP R&D Use ONLY |
|
Wet FIP |
6-7 mg/kg |
|
Dry FIP |
7-8 mg/kg |
|
Ocular or Neuro FIP |
8 mg/kg |
|
Increased ocular/neuro |
9 mg/kg |
|
Max ocular/neuro |
10 mg/kg |
Ascites / pleural effusion: 0.5ml/kg * body weight kg + 0.1 residue
FIP(Wet):0.4ml/kg * body weight kg + 0.1 residue
FIP(Dry): 0.6ml/kg * body weight kg + 0.1 residue
Eye / nerve entry: 0.7ml/kg * body weight kg + 0.1 residue
Recurrence: 0.9 ml / kg * body weight kg + 0.1 residue
Do not place in a sub-zero environment. Because this will result in the precipitation of active ingredients and the appearance of crystals, thus affecting the concentration and therapeutic effect.
